Pacific Biosciences Of California Debt to Equity Ratio 2009-2019 | PACB

Current and historical debt to equity ratio values for Pacific Biosciences Of California (PACB) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Pacific Biosciences Of California debt/equity for the three months ending September 30, 2019 was 0.84.
Pacific Biosciences Of California Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2019-09-30 $0.04B $0.05B 0.84
2019-06-30 $0.04B $0.08B 0.58
2019-03-31 $0.05B $0.10B 0.47
2018-12-31 $0.02B $0.11B 0.13
2018-09-30 $0.01B $0.13B 0.11
2018-06-30 $0.01B $0.09B 0.17
2018-03-31 $0.01B $0.10B 0.14
2017-12-31 $0.01B $0.09B 0.16
2017-09-30 $0.01B $0.10B 0.10
2017-06-30 $0.01B $0.12B 0.09
2017-03-31 $0.01B $0.07B 0.19
2016-12-31 $0.02B $0.09B 0.19
2016-09-30 $0.02B $0.10B 0.16
2016-06-30 $0.02B $0.11B 0.14
2016-03-31 $0.02B $0.09B 0.17
2015-12-31 $0.02B $0.07B 0.20
2015-09-30 $0.02B $0.04B 0.36
2015-06-30 $0.02B $0.03B 0.43
2015-03-31 $0.01B $0.04B 0.35
2014-12-31 $0.01B $0.06B 0.26
2014-09-30 $0.01B $0.05B 0.26
2014-06-30 $0.01B $0.06B 0.23
2014-03-31 $0.01B $0.08B 0.18
2013-12-31 $0.01B $0.07B 0.19
2013-09-30 $0.01B $0.08B 0.16
2013-06-30 $0.01B $0.10B 0.13
2013-03-31 $0.02B $0.11B 0.14
2012-12-31 $0.00B $0.11B 0.00
2012-09-30 $0.00B $0.13B 0.02
2012-06-30 $0.00B $0.15B 0.02
2012-03-31 $0.00B $0.17B 0.02
2011-12-31 $0.00B $0.19B 0.02
2011-09-30 $0.00B $0.21B 0.02
2011-06-30 $0.00B $0.23B 0.02
2011-03-31 $0.00B $0.25B 0.01
2010-12-31 $0.00B $0.28B 0.01
2010-09-30 $0.00B $-0.27B -0.01
2010-06-30 $0.00B 0.00
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2008-12-31 $0.00B $-0.10B -0.01
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.771B $0.079B
Pacific Biosciences of California, Inc. is engaged in the development, manufacture and commercialization of its single molecule, real-time, or SMRT technology-an integrated platform for genetic analysis. The SMRT technology uses the natural processing power of enzymes, combined with specially designed reagents and detection systems, to record individual biochemical events as they occur. The Company's technology platform comprises of the SMRT cells, Phospholinked nucleotides and the PacBio RS (an instrument that conducts, monitors and analyzes single molecule biochemical reactions in real time). Its product will find its application in both research institutions and commercial companies, including genome centers, government and academic institutions, genomic service providers, pharmaceutical companies and agriculture companies. Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $135.030B 27.97
Intuitive Surgical (ISRG) United States $69.146B 54.34
Edwards Lifesciences (EW) United States $49.761B 45.19
IDEXX Laboratories (IDXX) United States $24.870B 60.15
Fresenius Medical Care AG KGaA (FMS) Germany $22.755B 15.40
Olympus (OCPNY) Japan $22.193B 166.67
DexCom (DXCM) United States $21.455B 192.14
Teleflex (TFX) United States $17.795B 36.13
SONOVA HOLDING (SONVY) Switzerland $15.106B 0.00
Sysmex ADR (SSMXY) Japan $14.568B 39.21
Hologic (HOLX) United States $14.539B 22.22
Varian Medical Systems (VAR) United States $13.523B 32.06
STERIS (STE) Ireland $13.068B 28.86
Masimo (MASI) United States $9.058B 54.09
ABIOMED (ABMD) United States $8.193B 44.58
SARTORIUS AG (SARTF) Germany $6.731B 59.08
Penumbra (PEN) United States $5.601B 182.31
Globus Medical (GMED) United States $5.298B 32.69
Integra LifeSciences Holdings (IART) United States $5.178B 22.25
Elekta AB (EKTAY) Sweden $4.565B 38.55
Tandem Diabetes Care (TNDM) United States $4.108B 0.00
Nevro (NVRO) United States $3.839B 0.00
Wright Medical Group (WMGI) Netherlands $3.834B 232.38
LivaNova (LIVN) United Kingdom $3.638B 26.19
Integer Holdings (ITGR) United States $2.903B 19.87
Cantel Medical (CMD) United States $2.626B 25.70
Nihon Kohden (NHNKY) Japan $2.447B 24.63
Glaukos (GKOS) United States $2.140B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.608B 31.66
Veracyte (VCYT) United States $1.474B 0.00
Silk Road Medical (SILK) United States $1.295B 0.00
Tactile Systems Technology (TCMD) United States $1.208B 138.04
Natus Medical (NTUS) United States $1.159B 27.87
Mesa Laboratories (MLAB) United States $1.145B 42.45
Inogen (INGN) United States $1.139B 35.97
CryoLife (CRY) United States $1.114B 114.23
Luminex (LMNX) United States $1.069B 0.00
OPKO Health (OPK) United States $1.058B 0.00
Accelerate Diagnostics (AXDX) United States $0.984B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.907B 30.11
OrthoPediatrics (KIDS) United States $0.798B 0.00
Intersect ENT (XENT) United States $0.786B 0.00
Quotient (QTNT) Switzerland $0.698B 0.00
AxoGen (AXGN) United States $0.593B 0.00
AngioDynamics (ANGO) United States $0.579B 26.55
Si-Bone (SIBN) United States $0.546B 0.00
Alphatec Holdings (ATEC) United States $0.458B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.429B 12.97
Sientra (SIEN) United States $0.400B 0.00
Stereotaxis (STXS) United States $0.347B 0.00
RTI Surgical (RTIX) United States $0.329B 89.20
Semler Scientific (SMLR) United States $0.327B 45.46
Accuray (ARAY) United States $0.305B 0.00
SeaSpine Holdings (SPNE) United States $0.304B 0.00
IRadimed (IRMD) United States $0.300B 42.15
ViewRay (VRAY) United States $0.290B 0.00
CRH Medical (CRHM) Canada $0.290B 80.80
GenMark Diagnostics (GNMK) United States $0.288B 0.00
Fluidigm (FLDM) United States $0.273B 0.00
Restoration Robotics (VERO) Canada $0.178B 0.00
Spectral Diagnostics (EDTXF) Canada $0.129B 0.00
EDAP TMS S.A (EDAP) France $0.122B 32.31
ConforMIS (CFMS) United States $0.089B 0.00
Electromed (ELMD) United States $0.081B 29.15
Neuronetics (STIM) United States $0.081B 0.00
Vermillion (VRML) United States $0.080B 0.00
Second Sight Medical Products (EYES) United States $0.080B 0.00
Sensus Healthcare (SRTS) United States $0.067B 0.00
Apollo Endosurgery (APEN) United States $0.060B 0.00
Bioanalytical Systems (BASI) United States $0.057B 0.00
T2 Biosystems (TTOO) United States $0.053B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.039B 0.00
Helius Medical Technologies (HSDT) United States $0.038B 0.00
TransEnterix (TRXC) United States $0.032B 0.00
Ekso Bionics Holdings (EKSO) United States $0.029B 0.00
Neovasc (NVCN) Canada $0.028B 0.00
Ra Medical Systems (RMED) United States $0.027B 0.00
Navidea Biopharmaceuticals (NAVB) United States $0.026B 0.00
Xtant Medical Holdings (XTNT) United States $0.021B 0.00
DarioHealth (DRIO) Israel $0.017B 0.00
ENDRA Life Sciences (NDRA) United States $0.015B 0.00
OBALON THERPTCS (OBLN) United States $0.015B 0.00
ReWalk Robotics (RWLK) Israel $0.015B 0.00
American Shared Hospital Services (AMS) United States $0.014B 20.35
Nanovibronix (NAOV) United States $0.013B 0.00
Avinger (AVGR) United States $0.011B 0.00
Lianluo Smart (LLIT) China $0.010B 0.00
Dynatronics (DYNT) United States $0.008B 0.00
Micron Solutions (MICR) United States $0.007B 0.00
Allied Healthcare Products (AHPI) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
InspireMD (NSPR) Israel $0.004B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Viveve Medical (VIVE) United States $0.001B 0.00